Having been nominated for three years in a row, Check4Cancer was praised by the judges for its “high quality patient-centred, medically led service with clear targets for an effective one-stop approach diagnostic pathway” and its “level of clinical audit underpinning the outcomes”.
Accepting the award, Prof Gordon Wishart, Chief Medical Officer for Check4Cancer, commented “We are thrilled to have been recognised for our commitment to patient focused, reliable early cancer detection. Our best practice diagnostic pathways for breast & skin cancer have given patients rapid access to an accurate and reliable diagnosis, reducing average times to diagnosis and improving patients’ experience. We would like to thank the Health Investor Awards for recognising that out audited pathways have increased clinical governance in the private sector, and we would like to congratulate all the other finalists.”
Check4Cancer enables people to take ownership of their health, and that of their family, by providing cancer services that are innovative, validated and effective. The company’s team of cancer specialists has extensive clinical expertise, enabling Check4Cancer to provide award-winning services trusted by leading UK insurance providers and corporate sector clients.